Literature DB >> 16185250

Anatomy of melancholia: focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin.

Timothy G Dinan1, Lucinda V Scott.   

Abstract

Overactivity of the hypothalamic-pituitary-adrenal (HPA) axis characterized by hypercortisolism, adrenal hyperplasia and abnormalities in negative feedback is the most consistently described biological abnormality in melancholic depression. Corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) are the main secretagogues of the HPA/stress system. Produced in the parvicellular division of the hypothalamic paraventricular nucleus the release of these peptides is influenced by inputs from monoaminergic neurones. In depression, anterior pituitary CRH1 receptors are down-regulated and response to CRH infusion is blunted. By contrast, vasopressin V3 receptors on the anterior pituitary show enhanced response to AVP stimulation and this enhancement plays a key role in maintaining HPA overactivity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185250      PMCID: PMC1571537          DOI: 10.1111/j.1469-7580.2005.00443.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  40 in total

1.  Consistent reduction of ACTH responses to stimulation with CRH, vasopressin and hypoglycaemia in patients with major depression.

Authors:  R G Kathol; R S Jaeckle; J F Lopez; W H Meller
Journal:  Br J Psychiatry       Date:  1989-10       Impact factor: 9.319

2.  Vasopressin and corticotropin-releasing hormone gene responses to novel stress in rats adapted to repeated restraint.

Authors:  X M Ma; S L Lightman; G Aguilera
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

3.  Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.

Authors:  S Jard; R C Gaillard; G Guillon; J Marie; P Schoenenberg; A F Muller; M Manning; W H Sawyer
Journal:  Mol Pharmacol       Date:  1986-08       Impact factor: 4.436

4.  Vasopressin, major depression, and hypothalamic-pituitary-adrenocortical desensitization.

Authors:  M B Müller; R Landgraf; M E Keck
Journal:  Biol Psychiatry       Date:  2000-08-15       Impact factor: 13.382

5.  Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity.

Authors:  T G Dinan; E Lavelle; L V Scott; J Newell-Price; S Medbak; A B Grossman
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

6.  The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

Authors:  I Heuser; A Yassouridis; F Holsboer
Journal:  J Psychiatr Res       Date:  1994 Jul-Aug       Impact factor: 4.791

7.  Further neuroendocrine evidence of enhanced vasopressin V3 receptor responses in melancholic depression.

Authors:  T G Dinan; S O'Brien; E Lavelle; L V Scott
Journal:  Psychol Med       Date:  2004-01       Impact factor: 7.723

8.  Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.

Authors:  Y Tizabi; G Aguilera
Journal:  Neuroendocrinology       Date:  1992-11       Impact factor: 4.914

Review 9.  Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age.

Authors:  F A Antoni
Journal:  Front Neuroendocrinol       Date:  1993-04       Impact factor: 8.606

10.  Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH.

Authors:  R A Salata; D B Jarrett; J G Verbalis; A G Robinson
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

View more
  28 in total

Review 1.  Contribution of Vesicular Glutamate Transporters to Stress Response and Related Psychopathologies: Studies in VGluT3 Knockout Mice.

Authors:  Hanga Réka Horváth; Csilla Lea Fazekas; Diána Balázsfi; Subodh Kumar Jain; József Haller; Dóra Zelena
Journal:  Cell Mol Neurobiol       Date:  2017-08-03       Impact factor: 5.046

2.  Antepartum depression severity is increased during seasonally longer nights: relationship to melatonin and cortisol timing and quantity.

Authors:  Charles J Meliska; Luis F Martínez; Ana M López; Diane L Sorenson; Sara Nowakowski; Daniel F Kripke; Jeffrey Elliott; Barbara L Parry
Journal:  Chronobiol Int       Date:  2013-09-03       Impact factor: 2.877

3.  Gender differences in cardiovascular and corticoadrenal response to stress and drug cues in cocaine dependent individuals.

Authors:  Helen C Fox; Miguel Garcia; Kathleen Kemp; Verica Milivojevic; Mary Jeanne Kreek; Rajita Sinha
Journal:  Psychopharmacology (Berl)       Date:  2006-03-03       Impact factor: 4.530

4.  Interaction of stress, corticotropin-releasing factor, arginine vasopressin and behaviour.

Authors:  Eléonore Beurel; Charles B Nemeroff
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 5.  Minireview: Gut microbiota: the neglected endocrine organ.

Authors:  Gerard Clarke; Roman M Stilling; Paul J Kennedy; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  Mol Endocrinol       Date:  2014-06-03

Review 6.  Topical Review: The Emerging Field of Epigenetics: Informing Models of Pediatric Trauma and Physical Health.

Authors:  Nicole R Nugent; Amy Goldberg; Monica Uddin
Journal:  J Pediatr Psychol       Date:  2015-03-29

7.  Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imaging.

Authors:  Karine Fabio; Christophe Guillon; Carl J Lacey; Shi-fang Lu; Ned D Heindel; Craig F Ferris; Michael Placzek; Graham Jones; Michael J Brownstein; Neal G Simon
Journal:  Bioorg Med Chem       Date:  2011-12-20       Impact factor: 3.641

8.  Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436.

Authors:  David A Katz; Wei Liu; Charles Locke; Sandeep Dutta; Katherine A Tracy
Journal:  Psychopharmacology (Berl)       Date:  2015-09-26       Impact factor: 4.530

9.  Prenatal alcohol exposure increases vulnerability to stress and anxiety-like disorders in adulthood.

Authors:  Kim G C Hellemans; Pamela Verma; Esther Yoon; Wayne Yu; Joanne Weinberg
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

10.  Epigenetic Modulation of Mood Disorders.

Authors:  T Archer; M Oscar-Berman; K Blum; Ms Gold
Journal:  J Genet Syndr Gene Ther       Date:  2013-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.